Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which drug has the highest plasma protein binding?

Warfarin. ***Warfarin*** - **Warfarin** exhibits very **high plasma protein binding**, typically greater than 99%, primarily to albumin. - This high binding capacity means that only a small fraction of the drug is free and pharmacologically active. - Due to high protein binding, warfarin is susceptible to drug interactions when displaced from albumin. *Verapamil* - **Verapamil** has a relatively high plasma protein binding, around 90%, but it is not as high as warfarin. - Its binding is predominantly to **albumin** and alpha-1-acid glycoprotein. *Aspirin* - **Aspirin** (acetylsalicylic acid) has moderate plasma protein binding, usually between 50-90%, depending on the dosage. - It binds to **albumin** and can displace other protein-bound drugs. *GTN* - **Glyceryl trinitrate (GTN)** has moderate plasma protein binding, approximately 60%. - Its rapid onset and short duration of action are primarily due to its extensive first-pass metabolism and quick redistribution, rather than protein binding characteristics.

Q: In the context of pharmacology, which plasma protein do acidic drugs primarily bind to?

Albumin. ***Albumin*** - **Albumin** is the most abundant plasma protein and has multiple binding sites for a wide range of drugs, particularly **acidic drugs**. - Its high concentration and diverse binding capabilities make it the primary transporter for many **lipophilic** and **anionic drugs**. *Globulin* - **Globulins** are a diverse group of proteins, some of which bind to drugs, but they primarily transport **hormones**, **metals**, and **vitamins**, not acidic drugs. - They are less significant for binding acidic drugs compared to albumin. *α1-acid glycoprotein* - **α1-acid glycoprotein** primarily binds to **basic drugs** due to its numerous acidic residues. - While it plays a crucial role in binding basic compounds, it has limited affinity for acidic drugs. *None of the options* - This option is incorrect because **albumin** is a well-established and significant plasma protein for binding acidic drugs. - Specific plasma proteins are known to bind different types of drugs, and for acidic drugs, albumin is the primary binder.

Q: Which drug is commonly administered via subdermal implant?

Progestin. ***Progestin*** - **Progestins** (synthetic progestogens like **etonogestrel**) are commonly administered via subdermal implant (e.g., **Nexplanon**, Implanon) for **long-acting reversible contraception (LARC)**. - This method provides a continuous, low dose of hormone, offering effective birth control for **3 years**. - The implant is a small, flexible rod inserted subdermally in the upper arm. *Nicotine* - **Nicotine** is typically administered via **transdermal patches**, gum, inhalers, or nasal sprays for **smoking cessation**, not subdermal implants. - While it's delivered transdermally, the mechanism is through a patch placed on the skin surface, not an implant beneath it. *Fentanyl* - **Fentanyl** is a potent opioid primarily delivered via **transdermal patches** for chronic pain management, or intravenously for acute pain. - It is not administered via a subdermal implant; patches provide continuous release through skin absorption. *GTN* - **Glyceryl trinitrate (GTN)**, or nitroglycerin, is commonly administered as **sublingual tablets** or **transdermal patches** for angina. - It has a very short half-life and is not suitable for a slow-release subdermal implant due to its rapid vasodilatory effects.

Q: Which anaesthetic agent is neither metabolised by liver nor by kidney?

Atracurium. ***Atracurium*** - **Atracurium** undergoes **Hofmann elimination**, a non-enzymatic chemical degradation in plasma, and also **ester hydrolysis** by non-specific plasma esterases [2]. - This unique metabolism makes its elimination largely independent of **liver** and **kidney function**, making it a good choice for patients with organ dysfunction [2]. *Vecuronium* - Primarily metabolized by the **liver** into active and inactive metabolites [1]. - Its elimination can be prolonged in patients with **hepatic impairment** [1]. *Pancuronium* - Undergoes significant **hepatic metabolism** and subsequent **renal excretion** of both parent drug and metabolites [1]. - Its duration of action is significantly affected by both **liver** and **kidney dysfunction** [1]. *Rocuronium* - Primarily eliminated unchanged via **biliary excretion** (liver) [1]. - Its duration of action is prolonged in patients with **hepatic impairment** [1].

Q: What is the effect of adding epinephrine to lignocaine (a local anesthetic)?

Decreases absorption of local anesthetic. ***Decreases absorption of local anesthetic*** - Epinephrine causes **vasoconstriction** at the site of injection, which reduces the rate at which the local anesthetic is absorbed into the systemic circulation. - This slower absorption leads to a **higher concentration of the anesthetic** at the nerve fibers, prolonging its effect and reducing systemic toxicity. - This is the primary mechanism by which epinephrine enhances local anesthetic efficacy. *Increases distribution of local anesthetic* - The primary effect of epinephrine is to **localize the anesthetic** by reducing its systemic distribution. - This localization is achieved through **vasoconstriction**, which keeps the drug at the desired site rather than allowing it to distribute widely. *Decreases duration of local anesthetic* - By slowing absorption, epinephrine effectively **increases the duration of action** of the local anesthetic. - The anesthetic remains at the site of action for a longer period, providing **extended pain relief**. *Increases metabolism of local anesthetic* - Epinephrine does not directly affect the **metabolic rate** of local anesthetics. - The primary mechanism of metabolism for amides like lignocaine is in the **liver** by cytochrome P450 enzymes.

Q: Neuromuscular blocker of choice in renal failure is:

Atracurium. ***Atracurium*** - **Atracurium** is metabolized by **Hofmann elimination** and ester hydrolysis, which are non-organ dependent metabolic pathways [2]. - This makes it a suitable choice in patients with **renal or hepatic impairment** as its clearance is not significantly affected by organ dysfunction. *Pancuronium* - **Pancuronium** is primarily eliminated via **renal excretion**, with approximately 80% of the unchanged drug excreted by the kidneys. - In patients with renal failure, its **duration of action is significantly prolonged**, increasing the risk of prolonged paralysis. *Rocuronium* - **Rocuronium** is predominantly eliminated by the **liver**, but a significant portion (10-20%) is also excreted unchanged by the kidneys [1]. - While generally considered safer than pancuronium in renal failure, its **duration of action can still be moderately prolonged** in severe renal impairment [1]. *Tubocurare* - **Tubocurare** is primarily eliminated via **renal excretion**, with a small amount also metabolized by the liver. - Its use has largely been superseded by newer neuromuscular blockers due to its **tendency to cause histamine release** and significant prolongation of action in renal failure [3].

Q: Which of the following is not a phase I reaction?

Conjugation. ***Conjugation*** - **Conjugation** reactions are characteristic of **phase II metabolism**, where a polar molecule is added to the drug to increase its water solubility and facilitate excretion. - This process is distinct from phase I reactions which primarily involve exposure of functional groups. *Oxidation* - **Oxidation** is a primary **phase I metabolic reaction**, often mediated by cytochrome P450 enzymes. - It introduces or exposes a polar functional group on the drug molecule. *Reduction* - **Reduction** is another key **phase I metabolic reaction**, which involves the gain of electrons by a drug molecule. - This reaction can alter the drug's activity or prepare it for further metabolism. *Hydrolysis* - **Hydrolysis** is a **phase I metabolic reaction** that involves the cleavage of a chemical bond by water. - This process typically breaks down esters and amides, exposing functional groups.

Q: Which of the following best demonstrates the variability in drug responsiveness among individuals?

Quantal Dose Response Curve. ***Quantal Dose Response Curve*** - A **quantal dose-response curve** plots the percentage of individuals exhibiting a discrete, all-or-none effect against the log dose of a drug. - This curve directly illustrates the **variability in drug responsiveness** within a population by showing the range of doses required to produce a specific effect in different individuals. *Efficacy* - **Efficacy** refers to the maximum effect a drug can produce, regardless of the dose. - While efficacy is an important pharmacological parameter, it describes the drug's overall therapeutic potential, not the **individual variability** in response. *Potency* - **Potency** is a measure of the amount of drug needed to produce an effect of given intensity. - It relates to the absolute dose required for a particular effect but does not directly demonstrate the **inter-individual differences** in biological response. *Graded Dose Response Curve* - A **graded dose-response curve** depicts the relationship between the dose of a drug and the **magnitude of the effect** in a **single biological unit** (e.g., an individual, a tissue, or a cell). - This curve reflects the relationship between drug concentration and effect intensity, but not the **variability in response among different individuals** in a population.

Q: Which muscle relaxant is primarily excreted by the kidneys?

Gallamine. Everything in nature is balanced. ***Gallamine*** - **Gallamine** is predominantly cleared from the body through **renal excretion** (>90%), with very low hepatic metabolism. - Due to its high reliance on kidney function for elimination, **gallamine** is contraindicated in patients with **renal impairment**. [2] - **Note**: Gallamine has limited current clinical use and has been withdrawn from many markets, but remains important for understanding muscle relaxant pharmacokinetics. *Pancuronium* - **Pancuronium** has significant renal elimination (~40-50%), along with hepatic metabolism and biliary excretion. - While renal excretion is clinically important for **pancuronium** (making dose adjustment necessary in renal impairment), gallamine has a higher percentage of renal excretion. - Among **currently used** muscle relaxants, pancuronium shows the greatest dependence on renal function. *Vecuronium* - **Vecuronium** is mainly eliminated by **hepatic metabolism** (60-80%) and **biliary excretion**, with only a small fraction (10-25%) excreted renally. [1] - Its intermediate duration of action is attributed to rapid redistribution and hepatic metabolism, making it relatively safer for patients with renal dysfunction. [1] *Atracurium* - **Atracurium** undergoes unique elimination via **Hofmann degradation** (non-enzymatic chemical breakdown at physiological pH and temperature) and **ester hydrolysis**, independent of organ function. [3] - This makes it the preferred choice in patients with **renal** or **hepatic failure** as its metabolism does not rely on these organs. [3]

Question 1

Which drug has the highest plasma protein binding?

Accepted Answer

Warfarin

Answer

Verapamil

Answer

Aspirin

Answer

GTN

Question 2

In the context of pharmacology, which plasma protein do acidic drugs primarily bind to?

Accepted Answer

Albumin

Answer

Globulin

Answer

α1-acid glycoprotein

Answer

None of the options

Question 3

Which drug is commonly administered via subdermal implant?

Accepted Answer

Progestin

Answer

Nicotine

Answer

Fentanyl

Answer

GTN

Question 4

Which anaesthetic agent is neither metabolised by liver nor by kidney?

Accepted Answer

Atracurium

Answer

Vecuronium

Answer

Pancuronium

Answer

Rocuronium

Question 5

What is the effect of adding epinephrine to lignocaine (a local anesthetic)?

Accepted Answer

Decreases absorption of local anesthetic

Answer

Increases distribution of local anesthetic

Answer

Decreases duration of local anesthetic

Answer

Increases metabolism of local anesthetic

Question 6

Which of the following statements about the biodisposition of penicillins and cephalosporins is NOT accurate?

Accepted Answer

Renal tubular reabsorption of beta-lactams is inhibited by probenecid

Answer

Procaine penicillin G is used for intramuscular injection

Answer

Nafcillin and ceftriaxone are eliminated mainly by biliary secretion

Answer

Oral bioavailability is affected by lability to gastric acid

Question 7

Neuromuscular blocker of choice in renal failure is:

Accepted Answer

Atracurium

Answer

Pancuronium

Answer

Rocuronium

Answer

Tubocurare

Question 8

Which of the following is not a phase I reaction?

Accepted Answer

Conjugation

Answer

Oxidation

Answer

Reduction

Answer

Hydrolysis

Question 9

Which of the following best demonstrates the variability in drug responsiveness among individuals?

Accepted Answer

Quantal Dose Response Curve

Answer

Potency

Answer

Efficacy

Answer

Graded Dose Response Curve

Question 10

Which muscle relaxant is primarily excreted by the kidneys?

Accepted Answer

Gallamine

Answer

Vecuronium

Answer

Pancuronium

Answer

Atracurium

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?